SERVICE PROPERTIES TRUST - SHARES OF BENEFICIAL IN
2.7700
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.0500
+1.84%
Today's range
2.6800 - 2.8100
ISIN
N/A
Source
NASDAQ
-
Q3 EPS Forecast for Avis Budget Group Reduced by Analyst
25 Nov 2024 02:22:10 By Buzz FX
-
TG Therapeutics, Inc. (NASDAQ:TGTX) Given Average Recommendation of "Moderate Buy" by Brokerages
25 Nov 2024 02:22:10 By Buzz FX
-
Extra Space Storage Inc. (NYSE:EXR) Given Average Recommendation of "Hold" by Analysts
25 Nov 2024 02:22:10 By Buzz FX
-
Zoetis Inc. (NYSE:ZTS) Receives Average Recommendation of "Buy" from Analysts
25 Nov 2024 02:22:10 By Buzz FX
-
Namibia to vote in toughest election yet for ruling party
25 Nov 2024 02:21:21 By Buzz FX
-
U.S. Dollar Falls Against Majors
25 Nov 2024 02:21:21 By Buzz FX
-
Japan Leading Index Rises Less Than Estimated
25 Nov 2024 02:21:21 By Buzz FX
-
Zacks Research Raises Earnings Estimates for Canadian Solar
25 Nov 2024 02:21:10 By Buzz FX
-
DA Davidson Predicts NVIDIA's FY2025 Earnings (NASDAQ:NVDA)
25 Nov 2024 02:21:10 By Buzz FX
-
Wedbush Comments on NVIDIA's FY2025 Earnings (NASDAQ:NVDA)
25 Nov 2024 02:21:10 By Buzz FX
-
DA Davidson Forecasts Target's FY2025 Earnings (NYSE:TGT)
25 Nov 2024 02:21:10 By Buzz FX
-
Analysts Issue Forecasts for CBIZ's Q3 Earnings (NYSE:CBZ)
25 Nov 2024 02:21:10 By Buzz FX
-
Brokers Set Expectations for Coty's Q2 Earnings (NYSE:COTY)
25 Nov 2024 02:21:10 By Buzz FX
-
Q2 EPS Forecast for Exro Technologies Lifted by Analyst
25 Nov 2024 02:21:10 By Buzz FX
-
Zacks Research Cuts Earnings Estimates for Avanos Medical
25 Nov 2024 02:21:10 By Buzz FX
-
Zacks Research Reduces Earnings Estimates for Starbucks
25 Nov 2024 02:21:10 By Buzz FX
-
FY2025 EPS Estimates for Ross Stores Lifted by William Blair
25 Nov 2024 02:21:10 By Buzz FX
-
Quanta Services, Inc. (NYSE:PWR) Receives Average Recommendation of "Moderate Buy" from Analysts
25 Nov 2024 02:21:10 By Buzz FX
-
Cloudflare, Inc. (NYSE:NET) Receives Consensus Recommendation of "Hold" from Analysts
25 Nov 2024 02:21:10 By Buzz FX
-
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Rating of "Moderate Buy" from Analysts
25 Nov 2024 02:21:10 By Buzz FX